Our Research
We focus on chronic pain and migraine research. We collaborate with colleagues around the world from different scientific disciplines to make advancements in the basic science of pain and migraine. Our overarching goal is the development of new therapeutics.
Chronic Pain
Chronic pain affects 1.5 billion people across the globe. We are discovering and developing new therapeutics.
Migraine
Migraine affects 39 million people in the US and 1 billion worldwide. We aim to uncover the mechanisms that cause migraines.
Neuroimmunology
We focus on how the immune system interacts with the nervous system to cause chronic pain in animal models and patients.
RNA
Changes in gene expression drive chronic pain. Therapeutic manipulation of RNA biology is a key drug discovery target.
Publications and Grants
Publications
Since inception (2019), CAPS faculty have published over 60 papers. We are committed to producing high quality publications.
Grants
Since inception (2019), CAPS faculty have received over 33 grants or contracts and have raised over $25m in total funding to study chronic pain and migraine.